Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Bucolo

Showing results (121-130 of 201) with videos related to

Pageof 21
Sort By:
Retina (Philadelphia, Pa.)|March 8, 2017
POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXISMichele Reibaldi, Alfredo Pulvirenti, Teresio Avitabile, et al.
Molecular Vision|December 24, 2011
Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonistMonica Baiula, Antonino Spartà, Andrea Bedini, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 25, 2015
Folate status in type 2 diabetic patients with and without retinopathyGiulia Malaguarnera, Caterina Gagliano, Salvatore Salomone, et al.
Biochemical Pharmacology|June 10, 2015
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathwayGiovanni Giurdanella, Carmelina Daniela Anfuso, Melania Olivieri, et al.
Journal of Neuroinflammation|October 14, 2020
The immune system on the TRAIL of Alzheimer's diseaseChiara Burgaletto, Antonio Munafò, Giulia Di Benedetto, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Drug-Repurposing Strategy for Dimethyl FumarateSalvatore Giunta, Agata Grazia D'Amico, Grazia Maugeri, et al.
Biomed Research International|July 18, 2013
Lipoprotein(a) serum levels in diabetic patients with retinopathyGiulia Malaguarnera, Caterina Gagliano, Claudio Bucolo, et al.
International Journal of Molecular Sciences|March 4, 2020
A New Human Blood-Retinal Barrier Model Based on Endothelial Cells, Pericytes, and AstrocytesClaudia G Fresta, Annamaria Fidilio, Giuseppe Caruso, et al.
The British Journal of Ophthalmology|May 25, 2007
Protective effects of the sigma agonist Pre-084 in the rat retinaGiuseppina Cantarella, Claudio Bucolo, Giulia Di Benedetto, et al.
Molecular Pharmaceutics|November 8, 2024
From Preformulative Design to <i>in Vivo</i> Tests: A Complex Path of Requisites and Studies for Nanoparticle Ocular Application. Part 2: <i>In Vitro</i>, <i>Ex Vivo</i>, and <i>In Vivo</i> StudiesCinzia Cimino, Lorena Bonilla Vidal, Federica Conti, et al.
Pageof 21

Showing results (121-130 of 201) with videos related to

Sort By:
Pageof 21
Retina (Philadelphia, Pa.)|March 8, 2017
POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXISMichele Reibaldi, Alfredo Pulvirenti, Teresio Avitabile, et al.
Molecular Vision|December 24, 2011
Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonistMonica Baiula, Antonino Spartà, Andrea Bedini, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 25, 2015
Folate status in type 2 diabetic patients with and without retinopathyGiulia Malaguarnera, Caterina Gagliano, Salvatore Salomone, et al.
Biochemical Pharmacology|June 10, 2015
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathwayGiovanni Giurdanella, Carmelina Daniela Anfuso, Melania Olivieri, et al.
Journal of Neuroinflammation|October 14, 2020
The immune system on the TRAIL of Alzheimer's diseaseChiara Burgaletto, Antonio Munafò, Giulia Di Benedetto, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Drug-Repurposing Strategy for Dimethyl FumarateSalvatore Giunta, Agata Grazia D'Amico, Grazia Maugeri, et al.
Biomed Research International|July 18, 2013
Lipoprotein(a) serum levels in diabetic patients with retinopathyGiulia Malaguarnera, Caterina Gagliano, Claudio Bucolo, et al.
International Journal of Molecular Sciences|March 4, 2020
A New Human Blood-Retinal Barrier Model Based on Endothelial Cells, Pericytes, and AstrocytesClaudia G Fresta, Annamaria Fidilio, Giuseppe Caruso, et al.
The British Journal of Ophthalmology|May 25, 2007
Protective effects of the sigma agonist Pre-084 in the rat retinaGiuseppina Cantarella, Claudio Bucolo, Giulia Di Benedetto, et al.
Molecular Pharmaceutics|November 8, 2024
From Preformulative Design to <i>in Vivo</i> Tests: A Complex Path of Requisites and Studies for Nanoparticle Ocular Application. Part 2: <i>In Vitro</i>, <i>Ex Vivo</i>, and <i>In Vivo</i> StudiesCinzia Cimino, Lorena Bonilla Vidal, Federica Conti, et al.
Pageof 21